BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12866712)

  • 1. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
    Pałucha A; Pilc A
    Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of glutamate in the pathophysiology of depression.
    Palucha A; Pilc A
    Drug News Perspect; 2005 May; 18(4):262-8. PubMed ID: 16034483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
    Chaki S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood disorders: regulation by metabotropic glutamate receptors.
    Pilc A; Chaki S; Nowak G; Witkin JM
    Biochem Pharmacol; 2008 Mar; 75(5):997-1006. PubMed ID: 18164691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate-based antidepressants: preclinical psychopharmacology.
    Pilc A; Wierońska JM; Skolnick P
    Biol Psychiatry; 2013 Jun; 73(12):1125-32. PubMed ID: 23453290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glutamate on the action of antidepressants.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do glutamatergic agents represent a new class of antidepressant drugs? Part 1.
    Sanacora G
    J Clin Psychiatry; 2009 Oct; 70(10):1473-5. PubMed ID: 19906350
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of metabotropic glutamate receptors in animal models of Parkinson's disease.
    Senkowska A; Ossowska K
    Pol J Pharmacol; 2003; 55(6):935-50. PubMed ID: 14730087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.
    Skolnick P; Layer RT; Popik P; Nowak G; Paul IA; Trullas R
    Pharmacopsychiatry; 1996 Jan; 29(1):23-6. PubMed ID: 8852530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of glutamate in the pathophysiology of major depressive disorder.
    Hashimoto K
    Brain Res Rev; 2009 Oct; 61(2):105-23. PubMed ID: 19481572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does interaction between zinc and glutamate system play a significant role in the mechanism of antidepressant action?
    Nowak G
    Acta Pol Pharm; 2001; 58(1):73-5. PubMed ID: 11370292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate-based antidepressants: 20 years on.
    Skolnick P; Popik P; Trullas R
    Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
    Stahl SM
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):37-45. PubMed ID: 6090439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of glutamate signaling in preclinical and/or mechanistic models of depression.
    Tokita K; Yamaji T; Hashimoto K
    Pharmacol Biochem Behav; 2012 Feb; 100(4):688-704. PubMed ID: 21536063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM; Marek GJ; Johnson BG; Schoepp DD
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.
    Spooren W; Ballard T; Gasparini F; Amalric M; Mutel V; Schreiber R
    Behav Pharmacol; 2003 Jul; 14(4):257-77. PubMed ID: 12838033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test.
    Pałucha-Poniewiera A; Pilc A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):102-6. PubMed ID: 22651960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are compounds acting at metabotropic glutamate receptors the answer to treating depression?
    Palucha A
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1545-53. PubMed ID: 17107280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice.
    Pomierny-Chamioło L; Poleszak E; Pilc A; Nowak G
    Pharmacol Rep; 2010; 62(6):1186-90. PubMed ID: 21273676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.